Interestingly, Fan et al. and Della Corte et al. reported that the antidiabetic drug metformin exerts anticancer effects through the inhibition of the HH signaling pathway in breast cancer cells, decreasing the expression levels of SHH, SMO, PTCH and GLI1 [232,233]. This evidence concerns the gene SHH and breast cancer.